AGE-SPECIFIC DIFFERENCES IN DURATION OF CLINICAL PROTECTION AFTER VACCINATION WITH MENINGOCOCCAL POLYSACCHARIDE A VACCINE
- 1 July 1985
- journal article
- research article
- Published by Elsevier in The Lancet
- Vol. 326 (8447) , 114-118
- https://doi.org/10.1016/s0140-6736(85)90224-7
Abstract
No abstract availableThis publication has 5 references indexed in Scilit:
- Serum Antibodies to Capsular Polysaccharide Vaccine of Group A Neisseria meningitidis Followed for Three Years in Infants and ChildrenThe Journal of Infectious Diseases, 1980
- IMPAIRMENT OF THE IMMUNE RESPONSE TO VACCINATION AFTER ACUTE MALARIAThe Lancet, 1978
- Persistence of Antibody Following Immunization of Children With Groups A and C Meningococcal Polysaccharide VaccinesPediatrics, 1977
- Clinical Efficacy of Meningococcus Group A Capsular Polysaccharide Vaccine in Children Three Months to Five Years of AgeNew England Journal of Medicine, 1977
- 2ND CONTROLLED FIELD TRIAL OF A SEROGROUP-A MENINGOCOCCAL POLYSACCHARIDE VACCINE IN ALEXANDRIA1977